
These are this Wednesday’s top analyst upgrades, downgrades and initiations covered by 24/7 Wall St.
Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL) was downgraded to Sector Perform from Outperform at RBC Capital Markets.
Bank of New York Mellon Corp. (NYSE: BK) was started as Buy at Citigroup.
Ericsson (NASDAQ: ERIC) was downgraded to Neutral from Buy at UBS.
Goldcorp Inc. (NYSE: GG) was raised to Outperform from Neutral and the price target was raised to $33 from $32 at Credit Suisse.
HomeAway Inc. (NASDAQ: AWAY) was started as Buy at SunTrust Robinson Humphrey.
Marvell Technology Group Ltd. (NASDAQ: MRVL) was raised to Market Perform from Underperform at JMP Securities.
ALSO READ: The Best Performing DJIA Stocks of 2014
McDonald’s Corp. (NYSE: MCD) was reiterated as Overweight at J.P. Morgan with a $102 price target, although the firm admitted frustration and that McDonald’s is likely dead money.
Medivation Inc. (NASDAQ: MDVN) was downgraded to Neutral from Buy at Goldman Sachs.
Micron Technology Inc. (NASDAQ: MU) was reiterated as Buy with a $40 price target at Sterne Agee ahead of Thursday’s earnings report.
Morgan Stanley (NYSE: MS) was downgraded to Neutral from Overweight at J.P. Morgan.
Nabors Industries Ltd. (NYSE: NBR) was started as Outperform at Wells Fargo.
National Oilwell Varco Inc. (NYSE: NOV) was started as Market Perform at Wells Fargo.
Northern Trust Corp. (NASDAQ: NTRS) was started at Neutral by Citigroup.
Pan America Silver Corp. (NASDAQ: PAAS) was downgraded to Hold from Buy at TD Securities, and the price target was cut to $15 from $19.
Patterson-UTI Energy Inc. (NASDAQ: PTEN) was started as Outperform at Wells Fargo.
Rio Tinto PLC (NYSE: RIO) was raised to Overweight from Equal Weight at Morgan Stanley.
SAGE Therapeutics Inc. (NASDAQ: SAGE) was raised to Buy from Neutral at Goldman Sachs and the price target was set at $38 (versus a $29.56 close).
Sarepta Therapeutics Inc. (NASDAQ: SRPT) was started as Outperform and with a price target of $36 at Credit Suisse.
ALSO READ: Oppenheimer’s Top Stocks for the Rest of 2014
State Street Corp. (NYSE: STT) was started as Buy at Citigroup.
TearLab Corp. (NASDAQ: TEAR) was reiterated as Buy with a $8 price target at Canaccord Genuity, based on its new “flex” agreement sales program and updated R&D roadmap.
Ubiquiti Networks Inc. (NASDAQ: UBNT) was started as Buy with a $45 price target (versus a $38.20 close) at SunTrust Robinson Humphrey.
In case you missed Tuesday’s top analyst upgrades and downgrades, they included BlackBerry, Chevron, Exxon, SanDisk, Clorox and a dozen or so more.